Balyasny Asset Management’s 4D Molecular Therapeutics FDMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-37,044
Closed -$298K 2445
2022
Q3
$298K Buy
+37,044
New +$298K ﹤0.01% 1726